Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus

2.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

3.

To automate the biopharmaceutical facilities of Reliance Life Sciences, ABB India has won the contract.

4.

Telemedicine Not Reaching Rural Psychiatric Patients

5.

Risk of a second cancer after early breast cancer is low, say new findings


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot